FINGOLIMOD

FINGOLIMOD was reported 86195 times

FINGOLIMOD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OSSEOUS CRYPTOCOCCOSIS 14 0.6667
1 CONCENTRIC SCLEROSIS 6 0.4000
2 HAEMORRHAGIC ADRENAL INFARCTION 6 0.3750
3 IDIOPATHIC CD4 LYMPHOCYTOPENIA 3 0.3333
4 HEMIHYPERAESTHESIA 2 0.2857
5 JC POLYOMAVIRUS TEST 3 0.2000
6 TUMEFACTIVE MULTIPLE SCLEROSIS 32 0.1882
7 CRYPTOCOCCAL MENINGOENCEPHALITIS 21 0.1603
8 CD30 EXPRESSION 6 0.1333
9 CRYPTOCOCCAL CUTANEOUS INFECTION 18 0.0989
10 NEUROCRYPTOCOCCOSIS 6 0.0968
11 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 4 0.0952
12 EPILEPSIA PARTIALIS CONTINUA 4 0.0952
13 EXPANDED DISABILITY STATUS SCALE 7 0.0933
14 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 97 0.0777
15 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 15 0.0725
16 LYMPHOMATOID PAPULOSIS 21 0.0717
17 ENCHONDROMATOSIS 6 0.0698
18 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 7 0.0667
19 JANUS KINASE 2 MUTATION 6 0.0659
20 MALIGNANT MELANOMA STAGE 0 13 0.0622
21 RELAPSING-REMITTING MULTIPLE SCLEROSIS 51 0.0590
22 ANAL CYST 3 0.0517
23 CONGENITAL NEUROLOGICAL DISORDER 6 0.0513
24 ENZYME LEVEL ABNORMAL 7 0.0500
25 CUTANEOUS B-CELL LYMPHOMA 3 0.0492
26 VISCERAL LEISHMANIASIS 34 0.0471
27 MOLLUSCUM CONTAGIOSUM 25 0.0463
28 ADRENAL GLAND CANCER METASTATIC 3 0.0441
29 VIRAL MYELITIS 3 0.0435
30 HERPES SIMPLEX MENINGITIS 3 0.0423
31 CLINICALLY ISOLATED SYNDROME 4 0.0421
32 MENINGITIS CRYPTOCOCCAL 70 0.0400
33 ELECTROCARDIOGRAM QT SHORTENED 12 0.0396
34 VIRAL VASCULITIS 4 0.0374
35 RELAPSING MULTIPLE SCLEROSIS 11 0.0364
36 MONKEYPOX 10 0.0362
37 CONGENITAL CEREBRAL CYST 4 0.0357
38 SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED 9 0.0354
39 CHEST WALL MASS 9 0.0346
40 PRODUCT SUBSTITUTION ERROR 4 0.0342
41 CRYPTOCOCCOSIS 55 0.0337
42 LYMPHOPENIA 465 0.0328
43 MEDIASTINAL ABSCESS 4 0.0308
44 EYELID CONTUSION 2 0.0299
45 JC POLYOMAVIRUS TEST POSITIVE 34 0.0290
46 PARAGANGLION NEOPLASM 4 0.0274
47 UPPER MOTOR NEURONE LESION 6 0.0273
48 HERPES ZOSTER REACTIVATION 7 0.0267
49 VACCINATION FAILURE 43 0.0258
50 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 7 0.0239
51 ELECTROCARDIOGRAM PR SHORTENED 5 0.0238
52 CD19 LYMPHOCYTES DECREASED 3 0.0231
53 TRANSIENT TACHYPNOEA OF THE NEWBORN 9 0.0227
54 CHOROIDITIS 8 0.0214
55 HER2 POSITIVE BREAST CANCER 8 0.0213
56 SCHWANNOMA 4 0.0201
57 PAPILLOMA VIRAL INFECTION 33 0.0200
58 T-CELL TYPE ACUTE LEUKAEMIA 4 0.0196
59 PROCEDURAL PNEUMOTHORAX 3 0.0194
60 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 95 0.0190
61 HERPES ZOSTER INFECTION NEUROLOGICAL 3 0.0189
62 COMBINED IMMUNODEFICIENCY 3 0.0186
63 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 149 0.0180
64 PARAPARESIS 32 0.0179
65 ANOGENITAL WARTS 16 0.0179
66 CHOROID MELANOMA 2 0.0177
67 GAIT SPASTIC 6 0.0175
68 PLEOCYTOSIS 10 0.0172
69 OPHTHALMOPLEGIA 27 0.0171
70 AUTOIMMUNE HYPOTHYROIDISM 4 0.0168
71 PHAEOHYPHOMYCOSIS 8 0.0167
72 DYSMETRIA 10 0.0166
73 ESSENTIAL THROMBOCYTHAEMIA 6 0.0163
74 CEREBELLAR ISCHAEMIA 3 0.0161
75 JC VIRUS INFECTION 25 0.0156
76 LEIOMYOSARCOMA 6 0.0156
77 LOSS OF PROPRIOCEPTION 5 0.0155
78 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 29 0.0154
79 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 3 0.0154
80 RETINAL ANEURYSM 3 0.0150
81 HUMAN PAPILLOMA VIRUS TEST POSITIVE 6 0.0147
82 LIMBIC ENCEPHALITIS 4 0.0145
83 CD4 LYMPHOCYTES ABNORMAL 3 0.0143
84 PYRAMIDAL TRACT SYNDROME 6 0.0143
85 MARGINAL ZONE LYMPHOMA 3 0.0140
86 CRYPTOCOCCAL FUNGAEMIA 2 0.0140
87 HYPERLIPASAEMIA 7 0.0134
88 LYMPHOCYTE COUNT ABNORMAL 15 0.0133
89 BLOOD BRAIN BARRIER DEFECT 2 0.0132
90 NEEDLE FATIGUE 6 0.0131
91 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 3 0.0130
92 CONGENITAL HEARING DISORDER 2 0.0123
93 DYSDIADOCHOKINESIS 2 0.0117
94 SOLAR LENTIGO 11 0.0116
95 CHILLBLAINS 3 0.0115
96 EPIGLOTTIC OEDEMA 3 0.0114
97 BASOPHIL COUNT DECREASED 3 0.0114
98 HISTOPLASMOSIS DISSEMINATED 18 0.0113
99 CUTANEOUS TUBERCULOSIS 2 0.0110
100 HUMORAL IMMUNE DEFECT 4 0.0108
101 BLADDER DYSFUNCTION 11 0.0107
102 HERPES SIMPLEX REACTIVATION 4 0.0105
103 ALOPECIA UNIVERSALIS 3 0.0102
104 LARGE FOR DATES BABY 9 0.0102
105 VULVAL CANCER 6 0.0101
106 VARICELLA ZOSTER VIRUS INFECTION 21 0.0101
107 MACULAR OEDEMA 56 0.0100
108 CD8 LYMPHOCYTES DECREASED 2 0.0100
109 HERPES DERMATITIS 2 0.0099
110 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 2 0.0099
111 MUSCLE STRENGTH ABNORMAL 4 0.0095
112 CYSTOID MACULAR OEDEMA 18 0.0095
113 LIPOSARCOMA 3 0.0094
114 ANAL SPHINCTER ATONY 4 0.0093
115 DISSEMINATED CRYPTOCOCCOSIS 7 0.0092
116 HAEMORRHAGIC INFARCTION 5 0.0091
117 PERIPHERAL NERVE LESION 3 0.0091
118 QUADRIPARESIS 15 0.0090
119 EPILEPTIC ENCEPHALOPATHY 2 0.0090
120 NEUROMYELITIS OPTICA SPECTRUM DISORDER 12 0.0089
121 BRONCHIAL CARCINOMA 7 0.0089
122 MULTIPLE SCLEROSIS PSEUDO RELAPSE 3 0.0088
123 REBOUND EFFECT 99 0.0088
124 SINUSITIS FUNGAL 7 0.0087
125 BREAST DISCOMFORT 9 0.0087
126 LYMPHOCYTE COUNT DECREASED 153 0.0086
127 PRIMARY BILIARY CHOLANGITIS 4 0.0085
128 MYELITIS 13 0.0084
129 HERPES ZOSTER MENINGOENCEPHALITIS 3 0.0083
130 CERVICAL DYSPLASIA 18 0.0082
131 HEPATITIS E 13 0.0082
132 RETROGRADE AMNESIA 4 0.0079
133 MULTIPLE SCLEROSIS RELAPSE 519 0.0076
134 HUMAN POLYOMAVIRUS INFECTION 4 0.0075
135 CSF PRESSURE INCREASED 2 0.0075
136 TONSIL CANCER 6 0.0075
137 IMMUNE THROMBOCYTOPENIA 34 0.0074
138 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 6 0.0074
139 T-LYMPHOCYTE COUNT DECREASED 5 0.0073
140 CERVIX CARCINOMA 28 0.0072
141 CD4 LYMPHOCYTES DECREASED 15 0.0070
142 CERVIX CARCINOMA STAGE 0 2 0.0070
143 DILATED CARDIOMYOPATHY 7 0.0069
144 FOLLICULAR LYMPHOMA 6 0.0068
145 ACROCHORDON 9 0.0068
146 BRAIN STEM SYNDROME 5 0.0067
147 ANTI-THYROID ANTIBODY POSITIVE 3 0.0066
148 PNEUMONIA CRYPTOCOCCAL 6 0.0063
149 LUNG ADENOCARCINOMA 19 0.0063
150 SARS-COV-2 ANTIBODY TEST NEGATIVE 3 0.0063
151 INFECTION REACTIVATION 7 0.0061
152 CENTRAL NERVOUS SYSTEM INFECTION 7 0.0061
153 DEMYELINATION 25 0.0061
154 ENCEPHALITIS AUTOIMMUNE 8 0.0061
155 MONOPARESIS 11 0.0061
156 PRODUCT MEASURED POTENCY ISSUE 6 0.0060
157 MULTIPLE SCLEROSIS 283 0.0059
158 CENTRAL NERVOUS SYSTEM LESION 81 0.0059
159 CENTRAL SEROUS CHORIORETINOPATHY 4 0.0059
160 HEMIHYPOAESTHESIA 2 0.0057
161 NON-SMALL CELL LUNG CANCER METASTATIC 5 0.0057
162 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 2 0.0055
163 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0055
164 METASTASES TO MENINGES 12 0.0053
165 RETINAL VEIN OCCLUSION 15 0.0052
166 BICYTOPENIA 10 0.0051
167 DACTYLITIS 5 0.0051
168 AMBLYOPIA 3 0.0051
169 B-CELL LYMPHOMA 17 0.0050
170 ELECTROCARDIOGRAM T WAVE INVERSION 11 0.0050
171 CHORIORETINOPATHY 7 0.0049
172 POLYCYTHAEMIA VERA 4 0.0049
173 QUADRIPLEGIA 10 0.0049
174 BREAST NEOPLASM 5 0.0048
175 MUTISM 7 0.0048
176 RECTAL TENESMUS 6 0.0048
177 LYMPHOPROLIFERATIVE DISORDER 14 0.0048
178 CUTANEOUS T-CELL LYMPHOMA 6 0.0048
179 WHITE MATTER LESION 6 0.0047
180 SKIN PAPILLOMA 19 0.0047
181 MICROCEPHALY 6 0.0047
182 FRONTOTEMPORAL DEMENTIA 2 0.0047
183 SMALL CELL LUNG CANCER 7 0.0046
184 ATRIOVENTRICULAR BLOCK SECOND DEGREE 14 0.0046
185 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
186 ENCEPHALITIS CYTOMEGALOVIRUS 2 0.0046
187 VERTIGO POSITIONAL 8 0.0046
188 HEART DISEASE CONGENITAL 16 0.0045
189 PARESIS 10 0.0045
190 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0045
191 HEPATIC ENZYME DECREASED 2 0.0045
192 OPPORTUNISTIC INFECTION 8 0.0043
193 HERPES SIMPLEX ENCEPHALITIS 2 0.0043
194 CRANIAL NERVE DISORDER 3 0.0043
195 ADENOCARCINOMA OF COLON 8 0.0043
196 PROCALCITONIN INCREASED 5 0.0043
197 SPINAL CORD DISORDER 7 0.0043
198 SMEAR CERVIX ABNORMAL 6 0.0042
199 CRANIAL NERVE PARALYSIS 2 0.0042
200 BASAL CELL CARCINOMA 65 0.0042
201 ACCOMMODATION DISORDER 3 0.0041
202 NEUROENDOCRINE CARCINOMA OF THE SKIN 4 0.0041
203 AUTOIMMUNE HAEMOLYTIC ANAEMIA 14 0.0041
204 AMYLOIDOSIS 7 0.0041
205 LYMPHOCYTIC INFILTRATION 4 0.0040
206 HERPES ZOSTER OTICUS 2 0.0039
207 DIABETIC RETINAL OEDEMA 2 0.0039
208 OPTIC NEURITIS 35 0.0038
209 DECREASED IMMUNE RESPONSIVENESS 37 0.0038
210 EPHELIDES 2 0.0037
211 ATAXIA 44 0.0037
212 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 4 0.0037
213 EXECUTIVE DYSFUNCTION 2 0.0037
214 INVASIVE DUCTAL BREAST CARCINOMA 10 0.0037
215 B-LYMPHOCYTE COUNT DECREASED 5 0.0037
216 HEMIPARESIS 62 0.0037
217 DIFFUSE LARGE B-CELL LYMPHOMA 28 0.0036
218 SYSTEMIC INFECTION 6 0.0036
219 MEAN PLATELET VOLUME DECREASED 3 0.0036
220 FACIAL SPASM 4 0.0036
221 GAZE PALSY 6 0.0035
222 INTENTION TREMOR 2 0.0035
223 ENDOCRINE OPHTHALMOPATHY 3 0.0035
224 PAPILLARY THYROID CANCER 6 0.0034
225 FEBRILE INFECTION 4 0.0034
226 NUCHAL RIGIDITY 3 0.0033
227 CATARACT SUBCAPSULAR 2 0.0033
228 MONOCYTE COUNT DECREASED 4 0.0033
229 LYMPHOCYTOSIS 7 0.0032
230 PROCTITIS 9 0.0032
231 INFREQUENT BOWEL MOVEMENTS 8 0.0032
232 HUMAN HERPESVIRUS 6 INFECTION 6 0.0032
233 HEPATOSPLENOMEGALY 8 0.0031
234 GLIOMA 2 0.0031
235 OPTIC ATROPHY 5 0.0031
236 BRADYARRHYTHMIA 5 0.0030
237 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4 0.0030
238 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 6 0.0030
239 FLAT AFFECT 7 0.0030
240 AREFLEXIA 8 0.0030
241 BLOOD IMMUNOGLOBULIN M DECREASED 3 0.0030
242 MELANOCYTIC NAEVUS 13 0.0030
243 IMMUNOSUPPRESSION 26 0.0029
244 CLUMSINESS 8 0.0029
245 GLIOBLASTOMA 5 0.0029
246 EPISCLERITIS 2 0.0029
247 NEUROGENIC BLADDER 6 0.0028
248 MALIGNANT MELANOMA 38 0.0028
249 FACIAL DISCOMFORT 2 0.0028
250 CERVIX DISORDER 2 0.0028
251 ANTIBODY TEST ABNORMAL 2 0.0028
252 PERIODONTITIS 6 0.0028
253 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
254 CLAUSTROPHOBIA 3 0.0027
255 CEREBELLAR SYNDROME 6 0.0027
256 ADENOCARCINOMA 6 0.0027
257 PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0026
258 LUNG NEOPLASM 11 0.0026
259 ALLODYNIA 3 0.0026
260 EXTRADURAL ABSCESS 2 0.0025
261 COCCIDIOIDOMYCOSIS 3 0.0025
262 IIIRD NERVE PARALYSIS 2 0.0025
263 ENCEPHALITIS VIRAL 3 0.0025
264 NEUROLOGICAL SYMPTOM 14 0.0024
265 VENTRICULAR SEPTAL DEFECT 14 0.0024
266 GLIOBLASTOMA MULTIFORME 2 0.0024
267 HEPATITIS A 2 0.0024
268 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
269 SQUAMOUS CELL CARCINOMA 22 0.0023
270 TONIC CLONIC MOVEMENTS 3 0.0023
271 SPINAL CORD INJURY 4 0.0023
272 MICTURITION URGENCY 26 0.0023
273 CORONAVIRUS INFECTION 15 0.0023
274 CLOSTRIDIUM TEST POSITIVE 5 0.0023
275 CEREBRAL ATROPHY 9 0.0023
276 TALIPES 7 0.0023
277 ABDOMINAL NEOPLASM 2 0.0022
278 NORMAL NEWBORN 12 0.0022
279 CEREBRAL VENOUS THROMBOSIS 4 0.0022
280 COVID-19 PNEUMONIA 26 0.0022
281 SKIN DEPIGMENTATION 3 0.0022
282 MATERNAL EXPOSURE BEFORE PREGNANCY 15 0.0022
283 MENINGITIS VIRAL 3 0.0022
284 EXTENSOR PLANTAR RESPONSE 2 0.0022
285 MYELITIS TRANSVERSE 3 0.0021
286 NON-SMALL CELL LUNG CANCER 10 0.0021
287 BREAST MASS 14 0.0021
288 PRECANCEROUS SKIN LESION 3 0.0020
289 ENCEPHALITIS 14 0.0020
290 HYPERREFLEXIA 7 0.0020
291 BRAIN HERNIATION 6 0.0020
292 MENTAL FATIGUE 3 0.0020
293 MYELOFIBROSIS 6 0.0020
294 FACIAL PARESIS 7 0.0020
295 BRAIN STEM INFARCTION 2 0.0020
296 IMMUNODEFICIENCY 29 0.0019
297 SENSORY DISTURBANCE 31 0.0019
298 BLOOD CREATININE DECREASED 6 0.0019
299 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
300 DEAFNESS NEUROSENSORY 6 0.0018
301 ENDOMETRIAL CANCER 4 0.0018
302 SERUM SICKNESS 5 0.0018
303 MOTOR DYSFUNCTION 18 0.0018
304 URINE ABNORMALITY 8 0.0018
305 FOCAL DYSCOGNITIVE SEIZURES 2 0.0018
306 SENSORY LOSS 14 0.0017
307 HYPERTONIC BLADDER 5 0.0017
308 NEUROLOGICAL DECOMPENSATION 4 0.0017
309 CARDIAC DEATH 2 0.0017
310 SQUAMOUS CELL CARCINOMA OF SKIN 10 0.0017
311 GUILLAIN-BARRE SYNDROME 8 0.0017
312 THROMBOCYTOSIS 6 0.0016
313 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
314 PARALYSIS 23 0.0016
315 HEPATIC ENZYME ABNORMAL 8 0.0016
316 BAND SENSATION 2 0.0016
317 COORDINATION ABNORMAL 22 0.0016
318 ADJUSTMENT DISORDER 2 0.0015
319 LYMPHOCYTE COUNT INCREASED 5 0.0015
320 PYELONEPHRITIS ACUTE 3 0.0015
321 CATATONIA 8 0.0015
322 SUSPECTED COVID-19 5 0.0015
323 EXTRADURAL HAEMATOMA 2 0.0015
324 NEOPLASM RECURRENCE 5 0.0015
325 CLONUS 4 0.0015
326 SKIN CANCER 31 0.0014
327 ELECTRIC SHOCK SENSATION 4 0.0014
328 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
329 MUSCLE SPASTICITY 17 0.0014
330 ABORTION 4 0.0014
331 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
332 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
333 ENDOCARDITIS 7 0.0014
334 GENERALISED ANXIETY DISORDER 2 0.0014
335 URINE ANALYSIS ABNORMAL 4 0.0013
336 APHASIA 40 0.0013
337 ASTIGMATISM 2 0.0013
338 INFECTIOUS PLEURAL EFFUSION 2 0.0013
339 SKIN LESION 36 0.0013
340 GENITAL HERPES 2 0.0013
341 ECTOPIC PREGNANCY 4 0.0013
342 HAEMANGIOMA 3 0.0013
343 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
344 VITILIGO 3 0.0013
345 DISEASE RECURRENCE 60 0.0013
346 URINARY HESITATION 3 0.0013
347 VARICELLA 3 0.0013
348 COLON CANCER METASTATIC 2 0.0012
349 OVARIAN CANCER 11 0.0012
350 URINARY TRACT INFECTION BACTERIAL 3 0.0012
351 PATHOLOGICAL FRACTURE 6 0.0012
352 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
353 DISSEMINATED TUBERCULOSIS 3 0.0012
354 MENOPAUSE 3 0.0012
355 CERVICAL SPINAL STENOSIS 2 0.0012
356 HYPERBILIRUBINAEMIA 12 0.0012
357 PYELONEPHRITIS 10 0.0012
358 PARTIAL SEIZURES 6 0.0011
359 LEUKOPENIA 57 0.0011
360 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
361 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
362 RESPIRATORY RATE INCREASED 10 0.0011
363 MONOCYTE COUNT INCREASED 4 0.0011
364 GASTROINTESTINAL CARCINOMA 10 0.0011
365 LYMPHOMA 17 0.0011
366 CUTANEOUS VASCULITIS 4 0.0011
367 UROSEPSIS 10 0.0011
368 HERPES SIMPLEX 7 0.0011
369 INTRACRANIAL PRESSURE INCREASED 6 0.0011
370 LEUKOENCEPHALOPATHY 4 0.0011
371 DIARRHOEA HAEMORRHAGIC 10 0.0011
372 CHRONIC SINUSITIS 4 0.0011
373 HYPOGAMMAGLOBULINAEMIA 7 0.0011
374 STATUS EPILEPTICUS 12 0.0011
375 AUTOIMMUNE THYROIDITIS 4 0.0011
376 FACIAL PARALYSIS 9 0.0011
377 VASCULITIS 12 0.0010
378 PURPURA 9 0.0010
379 LYMPHOEDEMA 7 0.0010
380 LOW BIRTH WEIGHT BABY 8 0.0010
381 INTRACRANIAL ANEURYSM 4 0.0010
382 TRIGEMINAL NEURALGIA 4 0.0010
383 DYSAESTHESIA 3 0.0010
384 CHOLANGITIS SCLEROSING 2 0.0010
385 PIGMENTATION DISORDER 6 0.0010
386 PERSONALITY CHANGE 9 0.0010
387 OLIGURIA 6 0.0010
388 ATRIAL SEPTAL DEFECT 8 0.0010
389 HEPATIC PAIN 4 0.0009
390 SINUS BRADYCARDIA 9 0.0009
391 EXOPHTHALMOS 2 0.0009
392 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
393 ASPERGILLUS INFECTION 6 0.0009
394 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
395 COVID-19 160 0.0009
396 LIGAMENT SPRAIN 9 0.0009
397 OTITIS MEDIA 3 0.0009
398 BLADDER DISORDER 9 0.0009
399 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
400 ALANINE AMINOTRANSFERASE INCREASED 55 0.0009
401 TORSADE DE POINTES 7 0.0009
402 OSTEOMYELITIS 16 0.0009
403 PERONEAL NERVE PALSY 5 0.0009
404 REGURGITATION 3 0.0009
405 TEMPERATURE INTOLERANCE 9 0.0009
406 MICTURITION DISORDER 3 0.0009
407 POLYMENORRHOEA 3 0.0009
408 ARTHRITIS INFECTIVE 4 0.0009
409 COGNITIVE DISORDER 40 0.0009
410 EXPOSURE DURING PREGNANCY 53 0.0009
411 PAPULE 6 0.0009
412 INCONTINENCE 9 0.0009
413 MACULOPATHY 3 0.0008
414 SUBCUTANEOUS ABSCESS 4 0.0008
415 FOETAL EXPOSURE DURING PREGNANCY 67 0.0008
416 DYSARTHRIA 31 0.0008
417 MUCOUS STOOLS 4 0.0008
418 HERPES ZOSTER 46 0.0008
419 DRUG TOLERANCE 4 0.0008
420 THERAPEUTIC RESPONSE CHANGED 5 0.0008
421 NEUTROPHIL COUNT INCREASED 8 0.0008
422 APHTHOUS ULCER 6 0.0008
423 BREAST CANCER 72 0.0008
424 SKIN NECROSIS 4 0.0008
425 ACTINIC KERATOSIS 2 0.0008
426 DIPLOPIA 20 0.0008
427 PRODUCT SUBSTITUTION ISSUE 44 0.0008
428 SKIN ODOUR ABNORMAL 3 0.0008
429 ORAL CANDIDIASIS 10 0.0008
430 CYSTITIS 24 0.0008
431 NYSTAGMUS 4 0.0008
432 PREMATURE DELIVERY 12 0.0008
433 ABDOMINAL MASS 2 0.0007
434 HYPOAESTHESIA 111 0.0007
435 MUSCLE TIGHTNESS 12 0.0007
436 PERIPHERAL ISCHAEMIA 3 0.0007
437 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
438 NONSPECIFIC REACTION 4 0.0007
439 MUSCLE FATIGUE 3 0.0007
440 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
441 TONGUE DISCOMFORT 3 0.0007
442 CHOLECYSTITIS ACUTE 4 0.0007
443 PULMONARY TUBERCULOSIS 3 0.0007
444 DISEASE PROGRESSION 83 0.0007
445 METASTASIS 5 0.0007
446 PRODUCT SUPPLY ISSUE 5 0.0007
447 HEPATIC LESION 3 0.0007
448 VISUAL FIELD DEFECT 5 0.0007
449 MONOPLEGIA 3 0.0007
450 ONYCHOMYCOSIS 3 0.0007
451 DYSURIA 25 0.0007
452 BRADYCARDIA 36 0.0007
453 GASTROINTESTINAL INFECTION 6 0.0007
454 MENINGITIS ASEPTIC 3 0.0007
455 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
456 THYROID CANCER 8 0.0007
457 HEPATITIS B 4 0.0007
458 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
459 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
460 ATRIOVENTRICULAR BLOCK 5 0.0006
461 SKIN ABRASION 3 0.0006
462 HEPATITIS B REACTIVATION 2 0.0006
463 URINARY RETENTION 21 0.0006
464 MYELODYSPLASTIC SYNDROME 9 0.0006
465 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
466 RHINITIS 5 0.0006
467 LIVER FUNCTION TEST ABNORMAL 18 0.0006
468 ENCEPHALOPATHY 15 0.0006
469 POLYURIA 5 0.0006
470 STAPHYLOCOCCAL SEPSIS 3 0.0006
471 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
472 PULMONARY MASS 9 0.0006
473 THERAPY NON-RESPONDER 27 0.0006
474 PNEUMONIA ASPIRATION 15 0.0006
475 MENINGITIS 4 0.0006
476 LYMPHADENOPATHY 21 0.0006
477 METASTASES TO LYMPH NODES 4 0.0006
478 CARDIOVASCULAR DISORDER 15 0.0006
479 DIABETIC RETINOPATHY 2 0.0006
480 EYE MOVEMENT DISORDER 4 0.0006
481 HEPATITIS C 7 0.0006
482 CERVICAL VERTEBRAL FRACTURE 2 0.0006
483 PETECHIAE 6 0.0006
484 EXTRASYSTOLES 4 0.0006
485 BLOOD TEST ABNORMAL 8 0.0006
486 GAIT INABILITY 19 0.0006
487 DEPRESSIVE SYMPTOM 2 0.0006
488 DRUG INTOLERANCE 54 0.0006
489 HEPATIC ENZYME INCREASED 38 0.0006
490 GINGIVITIS 3 0.0006
491 ANAL INCONTINENCE 5 0.0006
492 BALANCE DISORDER 48 0.0006
493 HAEMATURIA 19 0.0006
494 PARAESTHESIA ORAL 8 0.0006
495 PANIC REACTION 4 0.0006
496 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
497 PARAESTHESIA 86 0.0005
498 PROSTATIC DISORDER 3 0.0005
499 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
500 HEPATOTOXICITY 12 0.0005
501 FLANK PAIN 5 0.0005
502 GAIT DISTURBANCE 102 0.0005
503 MITRAL VALVE INCOMPETENCE 6 0.0005
504 HERPES VIRUS INFECTION 3 0.0005
505 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
506 TREATMENT FAILURE 43 0.0005
507 AMENORRHOEA 9 0.0005
508 MUSCULAR WEAKNESS 58 0.0005
509 URINE ODOUR ABNORMAL 3 0.0005
510 DRUG-INDUCED LIVER INJURY 16 0.0005
511 KIDNEY INFECTION 10 0.0005
512 WHITE BLOOD CELL COUNT DECREASED 55 0.0005
513 LEUKOCYTOSIS 9 0.0005
514 LIMB DISCOMFORT 15 0.0005
515 CYTOMEGALOVIRUS INFECTION 8 0.0005
516 NERVOUS SYSTEM DISORDER 15 0.0005
517 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
518 GASTROENTERITIS 7 0.0005
519 NEOPLASM MALIGNANT 32 0.0005
520 ASCITES 14 0.0005
521 BRAIN OEDEMA 6 0.0005
522 SKIN PLAQUE 4 0.0005
523 ABSCESS LIMB 2 0.0005
524 INTERVERTEBRAL DISC DISORDER 2 0.0005
525 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
526 PREMATURE BABY 14 0.0005
527 IMMUNE SYSTEM DISORDER 6 0.0005
528 WALKING AID USER 3 0.0005
529 SARS-COV-2 TEST POSITIVE 6 0.0005
530 ADVERSE REACTION 6 0.0005
531 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
532 URINARY TRACT INFECTION 77 0.0005
533 EJECTION FRACTION DECREASED 7 0.0004
534 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
535 IRON DEFICIENCY 2 0.0004
536 VISUAL IMPAIRMENT 55 0.0004
537 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
538 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
539 HAEMOGLOBIN INCREASED 2 0.0004
540 INFARCTION 3 0.0004
541 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
542 BRAIN NEOPLASM 4 0.0004
543 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
544 AUTOIMMUNE HEPATITIS 3 0.0004
545 LIVER DISORDER 19 0.0004
546 HEART RATE DECREASED 15 0.0004
547 ABORTION SPONTANEOUS 17 0.0004
548 HAND FRACTURE 3 0.0004
549 SPINAL DISORDER 4 0.0004
550 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
551 RETINAL HAEMORRHAGE 3 0.0004
552 HAEMATOTOXICITY 4 0.0004
553 FUNGAL INFECTION 14 0.0004
554 PRODUCT PRESCRIBING ERROR 10 0.0004
555 FEELING JITTERY 8 0.0004
556 LIVER FUNCTION TEST INCREASED 9 0.0004
557 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
558 HYPERTHYROIDISM 6 0.0004
559 NOCTURIA 5 0.0004
560 VITAMIN D DEFICIENCY 4 0.0004
561 HYPOPHOSPHATAEMIA 3 0.0004
562 CYST 5 0.0004
563 HYPOAESTHESIA ORAL 6 0.0004
564 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
565 DYSLIPIDAEMIA 2 0.0004
566 VERTIGO 24 0.0004
567 VISUAL ACUITY REDUCED 13 0.0004
568 HEPATITIS 10 0.0004
569 INCREASED UPPER AIRWAY SECRETION 2 0.0004
570 DISTURBANCE IN ATTENTION 21 0.0004
571 THYROID DISORDER 6 0.0004
572 CEREBRAL ISCHAEMIA 2 0.0004
573 CONGENITAL ANOMALY 3 0.0004
574 VENTRICULAR EXTRASYSTOLES 4 0.0004
575 PLATELET COUNT INCREASED 5 0.0004
576 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
577 WITHDRAWAL SYNDROME 16 0.0004
578 MOVEMENT DISORDER 12 0.0004
579 COMPRESSION FRACTURE 2 0.0004
580 URINARY INCONTINENCE 11 0.0004
581 ANAL ABSCESS 2 0.0004
582 MUSCLE DISORDER 3 0.0004
583 NEURALGIA 9 0.0004
584 HYDROCEPHALUS 2 0.0004
585 METASTASES TO BONE 6 0.0004
586 CONFUSIONAL STATE 59 0.0004
587 VISION BLURRED 50 0.0004
588 HEMIPLEGIA 3 0.0004
589 EPILEPSY 11 0.0004
590 HYPERTENSIVE CRISIS 4 0.0004
591 INTERMENSTRUAL BLEEDING 2 0.0004
592 SKIN REACTION 5 0.0004
593 EYE PAIN 20 0.0004
594 HYPERTENSION 75 0.0004
595 VITAMIN D DECREASED 3 0.0004
596 PRESCRIBED UNDERDOSE 7 0.0004
597 SCAB 4 0.0004
598 SKIN HYPERPIGMENTATION 3 0.0003
599 EXERCISE TOLERANCE DECREASED 2 0.0003
600 ENTEROCOLITIS 2 0.0003
601 RESPIRATORY TRACT INFECTION 9 0.0003
602 SPINAL OSTEOARTHRITIS 3 0.0003
603 INFLUENZA LIKE ILLNESS 28 0.0003
604 HEAD DISCOMFORT 6 0.0003
605 CONDITION AGGRAVATED 103 0.0003
606 POLLAKIURIA 14 0.0003
607 IMPAIRED HEALING 11 0.0003
608 PNEUMONIA BACTERIAL 3 0.0003
609 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
610 INJECTION SITE DISCOLOURATION 4 0.0003
611 MOBILITY DECREASED 23 0.0003
612 BLEPHAROSPASM 2 0.0003
613 FOOT FRACTURE 6 0.0003
614 LUNG NEOPLASM MALIGNANT 13 0.0003
615 TRANSAMINASES INCREASED 7 0.0003
616 HALLUCINATION, AUDITORY 5 0.0003
617 GASTROINTESTINAL DISORDER 28 0.0003
618 INFLAMMATION 16 0.0003
619 CARDIAC FLUTTER 2 0.0003
620 INCOHERENT 2 0.0003
621 HEPATITIS ACUTE 2 0.0003
622 DYSGRAPHIA 2 0.0003
623 DEPRESSED MOOD 16 0.0003
624 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
625 HYPOTONIA 3 0.0003
626 BRAIN INJURY 3 0.0003
627 PYREXIA 103 0.0003
628 JAUNDICE 8 0.0003
629 PAIN OF SKIN 8 0.0003
630 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
631 SUBARACHNOID HAEMORRHAGE 3 0.0003
632 SLUGGISHNESS 3 0.0003
633 SPEECH DISORDER 15 0.0003
634 MASS 4 0.0003
635 INFECTION 41 0.0003
636 SEASONAL ALLERGY 4 0.0003
637 IMPAIRED WORK ABILITY 6 0.0003
638 ANGINA PECTORIS 8 0.0003
639 FATIGUE 217 0.0003
640 SYNOVITIS 5 0.0003
641 HYPOKINESIA 4 0.0003
642 C-REACTIVE PROTEIN INCREASED 10 0.0003
643 RESPIRATORY FAILURE 20 0.0003
644 APATHY 4 0.0003
645 EYE DISORDER 9 0.0003
646 PALPITATIONS 32 0.0003
647 THERAPY CESSATION 14 0.0003
648 EXTRA DOSE ADMINISTERED 11 0.0003
649 CEREBRAL DISORDER 2 0.0003
650 COLON CANCER 4 0.0003
651 PANCYTOPENIA 15 0.0003
652 SKIN INFECTION 3 0.0003
653 CHROMATURIA 6 0.0003
654 PANCREATITIS 14 0.0003
655 HEADACHE 165 0.0003
656 BREAST CANCER FEMALE 7 0.0003
657 HYPERTHERMIA 2 0.0003
658 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
659 EYELID OEDEMA 3 0.0003
660 RENAL DISORDER 12 0.0003
661 THERAPY PARTIAL RESPONDER 4 0.0003
662 BRAIN FOG 4 0.0003
663 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
664 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
665 BACTERAEMIA 3 0.0003
666 MENTAL STATUS CHANGES 7 0.0003
667 CHOLECYSTITIS 3 0.0003
668 GINGIVAL PAIN 2 0.0003
669 SEIZURE 29 0.0003
670 MUSCLE RIGIDITY 3 0.0003
671 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
672 NASOPHARYNGITIS 46 0.0002
673 MEMORY IMPAIRMENT 34 0.0002
674 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
675 TREMOR 41 0.0002
676 BLOOD POTASSIUM INCREASED 4 0.0002
677 CYTOPENIA 3 0.0002
678 CHOLELITHIASIS 8 0.0002
679 DIZZINESS 121 0.0002
680 ACUTE CORONARY SYNDROME 2 0.0002
681 BACK PAIN 56 0.0002
682 FALL 80 0.0002
683 DRUG WITHDRAWAL SYNDROME 21 0.0002
684 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
685 HYPOKALAEMIA 11 0.0002
686 CELLULITIS 12 0.0002
687 PSYCHOTIC DISORDER 7 0.0002
688 NEUTROPENIA 32 0.0002
689 HEPATIC CYTOLYSIS 3 0.0002
690 ADVERSE DRUG REACTION 21 0.0002
691 GENERAL PHYSICAL HEALTH DETERIORATION 27 0.0002
692 ARRHYTHMIA 11 0.0002
693 NIGHTMARE 8 0.0002
694 HYPONATRAEMIA 13 0.0002
695 AMNESIA 15 0.0002
696 MENTAL DISORDER 10 0.0002
697 ECZEMA 12 0.0002
698 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
699 EOSINOPHILIA 4 0.0002
700 GROIN PAIN 2 0.0002
701 ATRIAL FIBRILLATION 22 0.0002
702 EYE HAEMORRHAGE 3 0.0002
703 ISCHAEMIC STROKE 4 0.0002
704 CEREBRAL HAEMORRHAGE 8 0.0002
705 HAEMOLYTIC ANAEMIA 2 0.0002
706 CHILLS 26 0.0002
707 HEART RATE IRREGULAR 5 0.0002
708 DYSPHAGIA 21 0.0002
709 NEUTROPHIL COUNT DECREASED 9 0.0002
710 GINGIVAL BLEEDING 3 0.0002
711 PRODUCT AVAILABILITY ISSUE 5 0.0002
712 PANIC ATTACK 8 0.0002
713 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
714 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
715 INFLUENZA 24 0.0002
716 HEPATIC ENCEPHALOPATHY 2 0.0002
717 APPENDICITIS 2 0.0002
718 TACHYCARDIA 19 0.0002
719 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
720 OSTEONECROSIS 7 0.0002
721 PHOTOPHOBIA 4 0.0002
722 ABORTION INDUCED 2 0.0002
723 EYE INFLAMMATION 2 0.0002
724 LOWER LIMB FRACTURE 4 0.0002
725 AFFECT LABILITY 2 0.0002
726 PANCREATIC CARCINOMA 6 0.0002
727 GLAUCOMA 4 0.0002
728 ASTHENIA 78 0.0002
729 MENTAL IMPAIRMENT 5 0.0002
730 DIZZINESS POSTURAL 2 0.0002
731 CHOKING 4 0.0002
732 ORAL HERPES 4 0.0002
733 INFLAMMATORY BOWEL DISEASE 2 0.0002
734 MENORRHAGIA 4 0.0002
735 ACUTE MYOCARDIAL INFARCTION 6 0.0002
736 LABORATORY TEST ABNORMAL 6 0.0002
737 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
738 DISABILITY 4 0.0002
739 DISORIENTATION 8 0.0002
740 HYPERHIDROSIS 26 0.0002
741 BLOOD PRESSURE ABNORMAL 4 0.0002
742 AGEUSIA 5 0.0002
743 SPINAL FRACTURE 4 0.0002
744 CYTOKINE RELEASE SYNDROME 4 0.0002
745 PRODUCT PHYSICAL ISSUE 4 0.0002
746 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
747 BLINDNESS 8 0.0002
748 INSURANCE ISSUE 3 0.0002
749 THERAPY INTERRUPTED 14 0.0002
750 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
751 MUSCULOSKELETAL STIFFNESS 17 0.0002
752 MUSCULOSKELETAL CHEST PAIN 3 0.0002
753 ABDOMINAL PAIN 45 0.0002
754 HAEMATOMA 5 0.0002
755 FULL BLOOD COUNT ABNORMAL 2 0.0002
756 OBESITY 3 0.0002
757 SCIATICA 3 0.0002
758 DRUG INEFFECTIVE 248 0.0002
759 ABSCESS 3 0.0002
760 HYPOTHYROIDISM 6 0.0002
761 BREAST PAIN 2 0.0002
762 BODY HEIGHT DECREASED 2 0.0002
763 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
764 HOT FLUSH 14 0.0002
765 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
766 BACK INJURY 2 0.0002
767 PRODUCT DISPENSING ERROR 4 0.0002
768 MYOCARDIAL INFARCTION 32 0.0002
769 MEDICATION ERROR 10 0.0002
770 SKIN DISORDER 6 0.0002
771 FEELING COLD 5 0.0002
772 CANDIDA INFECTION 3 0.0002
773 EYE INFECTION 2 0.0002
774 AGITATION 13 0.0002
775 PRODUCT DOSE OMISSION ISSUE 52 0.0002
776 INJECTION SITE REACTION 12 0.0002
777 OFF LABEL USE 152 0.0002
778 MUSCLE TWITCHING 4 0.0002
779 ELECTROLYTE IMBALANCE 2 0.0002
780 METASTASES TO LIVER 3 0.0002
781 BLADDER CANCER 10 0.0002
782 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
783 MALAISE 74 0.0002
784 THIRST 3 0.0002
785 ACCIDENT 2 0.0002
786 CHEST PAIN 31 0.0002
787 HYPERLIPIDAEMIA 2 0.0002
788 CHEST DISCOMFORT 17 0.0002
789 BLOOD PRESSURE DECREASED 11 0.0002
790 TREATMENT NONCOMPLIANCE 9 0.0002
791 FEELING HOT 10 0.0002
792 ALOPECIA 32 0.0002
793 PAIN IN EXTREMITY 48 0.0002
794 HYPERCALCAEMIA 2 0.0002
795 HEART RATE INCREASED 16 0.0002
796 HEPATIC STEATOSIS 3 0.0002
797 BACTERIAL INFECTION 3 0.0002
798 FRACTURE 3 0.0002
799 ABDOMINAL PAIN LOWER 4 0.0002
800 HEAD INJURY 5 0.0002
801 PROTEINURIA 3 0.0002
802 PNEUMONIA 51 0.0002
803 COUGH 44 0.0002
804 CHOLESTASIS 3 0.0002
805 SINUSITIS 16 0.0002
806 UNRESPONSIVE TO STIMULI 4 0.0002
807 RHINORRHOEA 10 0.0002
808 SOMNOLENCE 31 0.0002
809 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
810 MUCOSAL INFLAMMATION 4 0.0002
811 NEPHROLITHIASIS 7 0.0002
812 HAEMATOCRIT DECREASED 3 0.0002
813 CATARACT 9 0.0002
814 INFUSION RELATED REACTION 10 0.0002
815 BLOOD PRESSURE INCREASED 23 0.0002
816 ABDOMINAL DISCOMFORT 25 0.0001
817 THERAPEUTIC RESPONSE DECREASED 9 0.0001
818 BLOOD BILIRUBIN INCREASED 4 0.0001
819 DYSKINESIA 6 0.0001
820 MOOD ALTERED 4 0.0001
821 MIGRAINE 14 0.0001
822 ACUTE HEPATIC FAILURE 2 0.0001
823 ILLNESS 15 0.0001
824 PERITONITIS 3 0.0001
825 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
826 SEPSIS 16 0.0001
827 APHONIA 2 0.0001
828 RENAL FAILURE 19 0.0001
829 HYPERKALAEMIA 5 0.0001
830 FEELING ABNORMAL 34 0.0001
831 JOINT INJURY 3 0.0001
832 OROPHARYNGEAL PAIN 13 0.0001
833 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
834 ANOSMIA 2 0.0001
835 INTENTIONAL PRODUCT MISUSE 12 0.0001
836 DEPRESSION 31 0.0001
837 CEREBROVASCULAR ACCIDENT 23 0.0001
838 CONTUSION 13 0.0001
839 TOOTH DISORDER 3 0.0001
840 HEPATIC FUNCTION ABNORMAL 5 0.0001
841 THROAT IRRITATION 6 0.0001
842 STOMATITIS 8 0.0001
843 PLEURAL EFFUSION 8 0.0001
844 MUSCLE SPASMS 24 0.0001
845 DEVICE RELATED INFECTION 2 0.0001
846 EMOTIONAL DISORDER 4 0.0001
847 BLOOD CHOLESTEROL INCREASED 6 0.0001
848 BURNING SENSATION 9 0.0001
849 PAIN 78 0.0001
850 WEIGHT INCREASED 28 0.0001
851 HIP FRACTURE 4 0.0001
852 CONVULSION 7 0.0001
853 LIVER INJURY 3 0.0001
854 DYSPEPSIA 12 0.0001
855 BRONCHITIS 9 0.0001
856 VOMITING 57 0.0001
857 CARDIAC ARREST 10 0.0001
858 FEBRILE NEUTROPENIA 8 0.0001
859 HYPOTENSION 24 0.0001
860 ROAD TRAFFIC ACCIDENT 5 0.0001
861 TYPE 2 DIABETES MELLITUS 4 0.0001
862 FLUSHING 12 0.0001
863 DELIRIUM 4 0.0001
864 NERVOUSNESS 6 0.0001
865 DISCOMFORT 7 0.0001
866 WEIGHT DECREASED 32 0.0001
867 CONSTIPATION 25 0.0001
868 GASTRITIS 3 0.0001
869 COLD SWEAT 2 0.0001
870 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
871 PNEUMONITIS 3 0.0001
872 LOSS OF CONSCIOUSNESS 14 0.0001
873 NAUSEA 86 0.0001
874 DECREASED APPETITE 25 0.0001
875 AGRANULOCYTOSIS 2 0.0001
876 NECK PAIN 6 0.0001
877 CARDIAC DISORDER 10 0.0001
878 INTENTIONAL DOSE OMISSION 3 0.0001
879 PRODUCTIVE COUGH 5 0.0001
880 INCREASED APPETITE 2 0.0001
881 LETHARGY 6 0.0001
882 ACUTE RESPIRATORY FAILURE 2 0.0001
883 DYSSTASIA 3 0.0001
884 DYSPHONIA 6 0.0001
885 ANXIETY 29 0.0001
886 URTICARIA 17 0.0001
887 ABNORMAL BEHAVIOUR 4 0.0001
888 ILL-DEFINED DISORDER 6 0.0001
889 OEDEMA PERIPHERAL 12 0.0001
890 THROMBOCYTOPENIA 11 0.0001
891 BODY TEMPERATURE INCREASED 2 0.0001
892 INSOMNIA 26 0.0001
893 DYSPNOEA 55 0.0001
894 HYPERSENSITIVITY 18 0.0001
895 DERMATITIS 2 0.0001
896 RENAL IMPAIRMENT 8 0.0001
897 OSTEOARTHRITIS 4 0.0001
898 MOOD SWINGS 3 0.0001
899 EPISTAXIS 7 0.0001
900 ACNE 7 0.0001
901 OEDEMA 5 0.0001
902 STAPHYLOCOCCAL INFECTION 3 0.0001
903 VIRAL INFECTION 3 0.0001
904 PULMONARY OEDEMA 4 0.0001
905 ANGER 3 0.0001
906 MYALGIA 15 0.0001
907 SKIN DISCOLOURATION 4 0.0001
908 DIARRHOEA 56 0.0001
909 DRY MOUTH 7 0.0001
910 SWELLING 8 0.0001
911 PSORIASIS 11 0.0001
912 PULMONARY EMBOLISM 8 0.0001
913 NEUROPATHY PERIPHERAL 8 0.0001
914 COMA 4 0.0001
915 RASH ERYTHEMATOUS 4 0.0001
916 BLOOD PRESSURE FLUCTUATION 2 0.0001
917 IRRITABILITY 5 0.0001
918 HYPERGLYCAEMIA 3 0.0001
919 FIBROMYALGIA 2 0.0001
920 ACCIDENTAL OVERDOSE 3 0.0001
921 CEREBRAL INFARCTION 2 0.0001
922 DYSGEUSIA 6 0.0001
923 SYNCOPE 8 0.0001
924 DYSPNOEA EXERTIONAL 3 0.0001
925 GASTRIC CANCER 2 0.0001
926 DEAFNESS 2 0.0001
927 ARTHRITIS 6 0.0001
928 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
929 PRURITUS 29 0.0001
930 EAR INFECTION 2 0.0001
931 PLATELET COUNT DECREASED 8 0.0001
932 THROMBOSIS 6 0.0001
933 FREQUENT BOWEL MOVEMENTS 2 0.0001
934 RECTAL HAEMORRHAGE 3 0.0001
935 SKIN BURNING SENSATION 5 0.0001
936 HYPERSOMNIA 2 0.0001
937 SEPTIC SHOCK 3 0.0001
938 ABDOMINAL DISTENSION 7 0.0001
939 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
940 HEPATIC FAILURE 2 0.0001
941 DIABETES MELLITUS 5 0.0001
942 TINNITUS 3 0.0001
943 ARTHRALGIA 26 0.0001
944 DEEP VEIN THROMBOSIS 4 0.0001
945 BLOOD CREATININE INCREASED 4 0.0001
946 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
947 HYPOXIA 2 0.0001
948 DRUG INTERACTION 9 0.0001
949 SLEEP DISORDER 4 0.0001
950 CRYING 2 0.0001
951 DEATH 47 0.0001
952 ADVERSE EVENT 5 0.0001
953 ABDOMINAL PAIN UPPER 11 0.0001
954 UNEVALUABLE EVENT 4 0.0001
955 RASH 23 0.0001
956 PERIPHERAL SWELLING 8 0.0001
957 NASAL CONGESTION 3 0.0001
958 CARDIAC FAILURE 4 0.0000
959 CARDIAC FAILURE CONGESTIVE 4 0.0000
960 SUICIDE ATTEMPT 3 0.0000
961 SKIN EXFOLIATION 4 0.0000
962 HYPOACUSIS 2 0.0000
963 ANGIOEDEMA 2 0.0000
964 DEHYDRATION 6 0.0000
965 SUICIDAL IDEATION 4 0.0000
966 ANAEMIA 8 0.0000
967 BLOOD GLUCOSE DECREASED 2 0.0000
968 INTERSTITIAL LUNG DISEASE 2 0.0000
969 DRY EYE 2 0.0000
970 AGGRESSION 2 0.0000
971 HAEMOGLOBIN DECREASED 4 0.0000
972 ERYTHEMA 8 0.0000
973 HAEMORRHAGE 4 0.0000
974 PRODUCT USE ISSUE 7 0.0000
975 ASTHMA 4 0.0000
976 BONE PAIN 2 0.0000
977 HOSPITALISATION 5 0.0000
978 INTENTIONAL OVERDOSE 2 0.0000
979 INJURY 2 0.0000
980 NO ADVERSE EVENT 5 0.0000
981 INJECTION SITE PAIN 8 0.0000
982 INJECTION SITE BRUISING 2 0.0000
983 EMOTIONAL DISTRESS 3 0.0000
984 TOXICITY TO VARIOUS AGENTS 4 0.0000
985 PRODUCT QUALITY ISSUE 3 0.0000
986 INCORRECT DOSE ADMINISTERED 4 0.0000
987 BLOOD GLUCOSE INCREASED 3 0.0000
988 ACUTE KIDNEY INJURY 2 0.0000